期刊文献+

Semaphorin3A及其受体与糖尿病血管并发症的关系 被引量:1

Relationship between Semaphorin3A, its receptors and diabetic vascular complications
原文传递
导出
摘要 Semaphorin3A是最初在神经系统中发现的分泌型糖蛋白.它有两个受体:Nrp和Plexin.Nrp为非酪氨酸激酶跨膜糖蛋白,Plexin为单通道跨膜蛋白家族成员.近年来发现,Semaphorin3A及其受体可介导内皮细胞受损,与糖尿病肾病、糖尿病视网膜病变、糖尿病神经病变等并发症密切相关,促进糖尿病血管并发症的发生与发展.对Semaphorin3A更深入的研究,将为糖尿病血管并发症的早期诊断、监测和治疗开辟新的途径. Semaphorin3A is a secretory glycoprotein originally found in the nervous system.Its has two receptors:Nrp and Plexin.Nrp is a non-tyrosine kinase transmembrane glycoprotein and Plexin is a member of single-channel transmembrane protein family.In recent years,it has been found that Semaphorin3A and its receptors can mediate the damage of endothelial cells and are closely related to the complications such as diabetic nephropathy,diabetic retinopathy and diabetic neuropathy,and promote the occurrence and development of diabetic vascular complications.Along with more and more researches of Semaphorin3A,new pathways for early diagnosis,monitor and intervention of diabetic vascular disease would be found.
出处 《国际内分泌代谢杂志》 2018年第1期55-58,共4页 International Journal of Endocrinology and Metabolism
基金 安徽省卫生计生委科研计划项目(2016QK021) 安徽省自然科学基金(1508085SQH220)
关键词 Semaphorin3A 糖尿病 血管并发症 Semaphorin3A Diabetes mellitus Vascular complications
  • 相关文献

参考文献3

二级参考文献74

  • 1李春媚,刘素雁,阮颖新,赵钰,朱兆杰,隋满姝.卡维地洛改善顺铂致肾小管上皮细胞凋亡[J].中华肾脏病杂志,2006,22(11):677-681. 被引量:2
  • 2蒋素华,丁小强,张晓丽,许迅辉,何广成,刘春凤,陈越.急性缺血再灌注损伤对肾脏的近期和远期作用[J].中华肾脏病杂志,2007,23(4):246-250. 被引量:4
  • 3Zaccolo M, Magalhaes P, Pozzan T. Compartmentalisation of cAMP and Ca (2+) signals. Curr Opin Cell Biol, 2002, 14: 160-166.
  • 4Bos JL, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rapl guanine-nucleotide-exchanger factor directly activated by cyclic AMP. Nature, 1998, 396: 474-477.
  • 5Bos JL. Epae: a new cAMP target and new avenues in cAMP research. Nat Rev Mol Cell Biol, 2003, 4: 733-738.
  • 6Rangarajan S, Enserink JM, Kuiperij HB, et al. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rapl upon stimulation of the beta 2-adrenergic receptor. J Cell Biol, 2003, 160: 487-493.
  • 7Fukuhara S, Sakurai A, Sano H, et al. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rapl signaling pathway. Mol Cell Biol, 2005, 25: 136-146.
  • 8Pannekoek WJ, van Dijk JJ, Chan OY, et al. Epacl and PDZ.GEF cooperate in Rapl mediated endothelial junction control, Cell Signal, 2011, 23: 2056-2064.
  • 9Li Y, Konings IB, Zhao J, et al. Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2. Am J Physiol Renal Physiol, 2008, 295: F525-F533.
  • 10Sun L, Kondeti VK, Xie P, et al. Epacl-Mediated, High Glucose-Induced Renal Proximal Tubular Cells Hypertrophy via the Akt/p21 Pathway. Am J Pathol, 2011, 179: 1706-1718.

共引文献9

同被引文献12

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部